XCUR (Exicure) OCF Margin %: 0.00% (As of Mar. 2026)


XCUR Exicure Inc XCUR
30 GF Score
Price $2.49
GF Value $0.54
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Exicure OCF Margin %?

Exicure XCUR -4.40% 30 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates XCUR with a GF Score™ of 30/100 and a GF Value™ of $0.54 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 959 Biotechnology companies, Exicure ranks worse than 104275.18% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Exicure's Cash Flow from Operations for the three months ended in Mar. 2026 was $-1.14 Mil. Exicure's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Exicure's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Exicure's current OCF Yield % is -51.13%.

The historical rank and industry rank for Exicure's OCF Margin % or its related term are showing as below:


During the past 10 years, the highest OCF Margin % of Exicure was 7208.90%. The lowest was -16514.41%. And the median was -220.00%.

XCUR's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

Exicure OCF Margin % Related Terms

Exicure OCF Margin % Historical Data

* Premium members only.

The historical data trend for Exicure's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exicure OCF Margin % Chart

Exicure Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,208.90 -123.70 0.00 -582.00 0.00

Exicure Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XCUR
30GF Score
Exicure Inc XCUR
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Exicure OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Exicure's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-8.555/0
= %

Exicure's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-1.142/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Exicure (XCUR) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Exicure and its competitors. According to the industry distribution chart, Exicure ranks #999999 out of 959 companies in the Biotechnology industry.
Is Exicure's OCF Margin % too high?
Exicure's current OCF Margin % is 0.00%. Based on the distribution chart, Exicure ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Exicure has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Exicure's OCF Margin % compare to GRTX and AEON?
According to the Biotechnology industry distribution chart, Exicure ranks #999999 out of 959 companies for OCF Margin %. This places Exicure in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Exicure and its competitors. Exicure's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exicure stock overvalued right now?
Based on GuruFocus' analysis, Exicure (XCUR) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.54, compared to a current price of $2.49 — trading 360.2% above its estimated fair value. The current OCF Margin % is 0.00%. Exicure's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Exicure (XCUR), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Exicure (XCUR) Overvalued in 2026?

Based on GuruFocus' analysis, Exicure stock appears to be overvalued. The current stock price of $2.49 is trading 360.2% above its estimated GF Value™ of $0.54. GuruFocus considers Exicure to be Significantly Overvalued.

Key valuation signals for XCUR:

  • OCF Margin %: 0.00%
  • GF Value™: $0.54 vs. price of $2.49 (360.2% above fair value)
  • GF Score™: 30/100 with 3 warning signs

No single metric tells the full story. See the XCUR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Exicure Business Description

Other Exchanges 2H0:Germany
Address 400 Seaport Court, Suite 102, Redwood City, CA, USA, 94063
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.
30GF Score

Get the complete analysis for XCUR

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.49
Price
$0.54
GF Value